Results 221 to 230 of about 207,835 (296)

Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery

, 2006
Narayan Bhattarai, Hassna R. Ramay, Shinn‐Huey S. Chou, Miqin Zhang   +3 more
openalex   +1 more source

Nanotubes: A New Carrier for Drug Delivery Systems [PDF]

, 2008
Yong Zhou
openalex   +1 more source

SARS‐CoV‐2 Is Linked to Brain Volume Loss in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The impact of SARS‐CoV‐2 infection on brain and spinal cord pathology in patients with multiple sclerosis (pwMS) remains unclear. We aimed to describe changes in brain lesion activity and brain and spinal cord volumes following SARS‐CoV‐2 infection.
Tomas Uher, Dominika Stastna, Ingrid Menkyova, Vaclav Capek, Jiri Lindner, Petra Nytrova, Jan Krasensky, Eliza Varju, Miguel D'haeseleer, Eva Kubala Havrdova, Dana Horakova, Manuela Vaneckova, Niels Bergsland   +12 more
wiley   +1 more source

Enhancing capture efficiency of drug-carrier particles in the carotid sinus by utilizing a combination of magnetic fields: A numerical approach. [PDF]

Heliyon
Aali M, Esmaeili A, Ebrahimi H, Azami A, Kavoosi A, Davoodabadi Farahani S.   +5 more
europepmc   +1 more source

Enhancement of Anticancer Activity in Antineovascular Therapy Is Based on the Intratumoral Distribution of the Active Targeting Carrier for Anticancer Drugs

, 2006
Noriyuki Maeda, Souichiro Miyazawa, Kosuke Shimizu, Tomohiro Asai, Sei Yonezawa, Sadaya Kitazawa, Yukihiro Namba, Hideo Tsukada, Naoto Oku   +8 more
openalex   +2 more sources

Fabrication of magnetic porous hollow silica drug carriers using CaCO3∕Fe3O4 composite nanoparticles and cationic surfactant double templates [PDF]

, 2008
Hui Ma, Jisheng Zhou, Daniela Caruntu, Ming Yu, J. F. Chen, C.J. O’Connor, Weilie Zhou   +6 more
openalex   +1 more source

Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Despite the availability of effective therapies for Multiple Sclerosis (MS), the unpredictable nature of disease progression and the variability in individual treatment outcomes call for reliable biomarkers. This pilot study aims to investigate the potential of plasma circulating microRNAs (miRNAs) as predictive biomarkers for ...
Fortunata Carbone, Alessandra Colamatteo, Teresa Micillo, Gianmarco Abbadessa, Silvia Garavelli, Clorinda Fusco, Claudia Russo, Francesco Perna, Federica Garziano, Claudia La Rocca, Maria Mottola, Giorgia Teresa Maniscalco, Simona Bonavita, Antonio Luca Spiezia, Alessia Castiello, Roberta Lanzillo, Vincenzo Brescia Morra, Claudio Procaccini, Paola de Candia, Giuseppe Matarese   +19 more
wiley   +1 more source

Factors for Rituximab Refractoriness in AQP4‐IgG+ NMOSD: A Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a severe autoimmune condition of the central nervous system (CNS), often associated with aquaporin‐4 antibodies (AQP4‐IgG). Rituximab, a CD20+ B‐cell depleting monoclonal antibody, is widely used as first‐line therapy.
Mariano Marrodan, María A. Piedrabuena, María A. Zarate, Sofía Rodríguez Murúa, Ezequiel I. Surace, Mauricio F. Farez, Marcela P. Fiol, María C. Ysrraelit, Jorge Correale   +8 more
wiley   +1 more source

Study of Polyethylene Oxide-<i>b</i>-Poly(<i>ε</i>-caprolactone-<i>ran</i>-<i>δ</i>-valerolactone) Amphiphilic Architectures and Their Effects on Self-Assembly as a Drug Carrier. [PDF]

Polymers (Basel)
Wang C, Wu T, Li Y, Liu J, Wang Y, Wang K, Li Y, Leng X.   +7 more
europepmc   +1 more source

Environmentally responsive peptides as anticancer drug carriers☆ [PDF]

, 2009
Suhaas Aluri, Siti M. Janib, J. Andrew MacKay   +2 more
openalex   +1 more source